Trial Details
COMPLETEDBasic Information
| Clinical ID | c3601 |
|---|---|
| Identifier | NCT01802073 |
| Trial Title | Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Primary Sclerosing Cholangitis |
| Interventions | DRUG: Oral Vancomycin |
Participant Information
| Sponsor | Stanford University |
|---|---|
| City | Palo Alto |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2012-01 |
|---|---|
| Primary Completion Date | 2015-08 |
| Completion Date | 2015-08 |